 |
 |
|
|
|
AccSys Ships Model PL-4 Linac to Brookhaven National Laboratory
Pleasanton, CA - April 14, 1997
Dr. Robert W. Hamm, President and CEO of AccSys Technology, Inc. announced
today the installation of the company's PL-4 compact radiofrequency (rf) proton
linear accelerator (linac) at Brookhaven National Laboratory (BNL) for use by
Dr. David Schlyer's chemistry group under a Department of Energy Cooperative
Research and Development Agreement (CRADA) [DOE CRADA Number
BNL-C-95-05]. According to Dr. Hamm, "The installation of this Model PL-4
linac is a major milestone in our ongoing relationship with Dr. Schlyer's group
of world class isotope production target and radiochemistry scientists at BNL."
The PL-4 will serve as a permanent "test bed" for development of high
performance positron isotope production targets for use with the rf proton
linacs produced by AccSys. Validation of a target designed under the CRADA for
fluorine-18 production using the AccSys Model PL-7 linac system was announced in
November of 1996. Targets for the production of the other medically-important
positron emitting isotopes, carbon-11, nitrogen-13 and oxygen-15, are currently
under development.
AccSys Technology is the world's leading commercial producer of rf ion linacs. The Company's PULSAR® product line represents the next generation of
positron radiotracer production equipment. Positron radiotracers are used in
medicine for research and diagnostic imaging studies using techniques such as
Positron Emission Tomography (PET) or high energy Single Photon Emission
Computed Tomography (SPECT). PULSAR® establishes a new standard in optimized
performance for efficient, cost-effective and reliable production of
positron-labeled radiotracers for regional distribution, physiologic imaging
research and clinical diagnostic applications.
PULSAR® is based on the compact PL-7 proton linac which incorporates the
latest in advanced rf ion linac technology. Its modest 7.0 MeV energy and high
proton beam current combine to give outstanding performance in a compact,
affordable package. In addition to providing high production yields, the
PULSAR® solution to positron radiotracer production avoids the complexity,
weight, shielding and cost penalties of cyclotron systems.
Dr. Jerry Robinson, Vice President and PET Program Manager at AccSys,
commented: "The PL-4 at Brookhaven will continue to be a major resource for the
development of advanced, high performance targets for PULSAR®. This gives
AccSys, working with Dr. Schlyer's group, the ability to quickly and
definitively evaluate the performance, reliability and robustness new target
concepts using a 'real world' platform."
AccSys Technology, Inc. was founded in 1985 to commercialize advanced
radiofrequency (rf) ion linac technology for applications in medicine, industry
and research, with emphasis on developing an innovative system for producing the
short-lived radiotracers used in medical positron imaging. AccSys has produced
and installed 14 rf ion linac systems worldwide since 1987.
|
|
|
|
|
News |
Downloads |
FAQ |
Contact Us |
